Merck announced earlier this week that it will expand the value of its investments in the US to more than $70 billion (€60.4 billion), as the drugmaker looks to scale up its manufacturing and research footprint in the country.: Krisztian Bocsi/Bloomberg

Merck, the German life sciences multinational,

📰

Continue Reading on The Irish Times

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →